Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prions

S B Prusiner1

  • 1Departments of Neurology and of Biochemistry and Biophysics, University of California, San Francisco, CA 94143, USA.

Proceedings of the National Academy of Sciences of the United States of America
|November 13, 1998
PubMed
Summary
This summary is machine-generated.

Prions are novel infectious agents composed of misfolded prion proteins (PrPSc) that cause fatal neurodegenerative diseases. Understanding prion structure and replication is key to developing treatments for these and other brain disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper induces conformational changes in the N-terminal part of cell-surface PrPC.

Archives of virology·2006
Same author

Engineering the prion protein using chemical synthesis.

The journal of peptide research : official journal of the American Peptide Society·2002
Same author

Inherited prion disease caused by the V210I mutation: transmission to transgenic mice.

Neurology·2002
Same author

Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.

Journal of molecular biology·2001
Same author

Doppel-induced cerebellar degeneration in transgenic mice.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Huntington disease phenocopy is a familial prion disease.

American journal of human genetics·2001
Same journal

Tau protein as a regulator of mitochondrial function and dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Epigenetic regulation of mesenchymal BMP signaling directs postnatal organ innervation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Single-shot wide-field biochemical imaging at 1 kHz frame rate.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Morphogenesis and topological evolution of a frustrated nematic liquid crystal under confinement.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

B cell-intrinsic CXCR3 drives efficient generation of ectopic pulmonary germinal center responses to influenza A virus infection.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Infectious Diseases

Background:

  • Prions are unique infectious agents responsible for fatal neurodegenerative diseases.
  • Prion diseases, including BSE, scrapie, and CJD, involve the modification of prion protein (PrP).
  • Prions lack nucleic acid and consist of abnormal prion protein (PrPSc) formed from normal cellular PrP (PrPC).

Purpose of the Study:

  • To elucidate the novel mechanism of prion replication and disease causation.
  • To investigate the structural basis of prion strain diversity.
  • To explore potential therapeutic strategies for prion diseases.

Main Methods:

  • Analysis of prion protein (PrP) structure and conversion.
  • Transgenic studies in mice expressing modified prion protein genes.

Related Experiment Videos

  • Generation and characterization of miniprions.

    • Main Results:

    • Prion diseases result from the conversion of normal PrPC to abnormal PrPSc, characterized by increased beta-sheet content.
    • Prion strain properties are encoded in the tertiary structure of PrPSc, not a nucleic acid genome.
    • Transgenic studies support a template-directed refolding mechanism for PrPSc formation.
    • Miniprions with deleted residues exhibit distinct biological properties, aiding structural studies.

    Conclusions:

    • Prions represent a novel class of pathogens with implications for protein structural plasticity.
    • Understanding prion replication mechanisms may offer insights into broader protein misfolding disorders.
    • Research into prion diseases could lead to new therapeutic approaches for neurodegenerative conditions.